Back to Search
Start Over
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
- Source :
- Therapeutic Advances in Neurological Disorders, Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
- Publication Year :
- 2021
- Publisher :
- SAGE Publications, 2021.
- Subjects :
- finfolimod
Coronavirus disease 2019 (COVID-19)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Disease
multiple sclerosis
Immune system
ocrelizumab
Medicine
In patient
RC346-429
Letter to the Editor
Pharmacology
Messenger RNA
business.industry
Multiple sclerosis
COVID-19
medicine.disease
mRNA vaccine
Neurology
Immunology
Ocrelizumab
Neurology. Diseases of the nervous system
Neurology (clinical)
business
cladrivine
medicine.drug
Subjects
Details
- ISSN :
- 17562864
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Therapeutic Advances in Neurological Disorders
- Accession number :
- edsair.doi.dedup.....0e802333a27c79a8a733c50560b2064f